Investing Profile

James Kasuboski

InvestorVC
Partner and Head of Research at Luma Group
omx.vcBoston, Massachusetts
Photo of James Kasuboski, Partner at Luma Group

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Pfizer Network
13 CONNECTIONS
Luma Group Partner
$500K - $15.0M
$7.8M
Investor Member Advanced Research Projects Agency for Health (ARPA-H)2025 - Present
Partner and Head of Research Luma Group2024 - Present
Advisor Chicago Biomedical Consortium2022 - Present
Grant Reviewer DR RALPH AND MARIAN FALK MEDICAL RESEARCH TRUST2020 - Present
Co-Founder Avilar Therapeutics2019 - Present
Mentor Nucleate2019 - Present
SBIR/STTR Grant Reviewer National Cancer Institute (NCI)2018 - Present
Board Member ReAx Biotechnologies2021 - 2024
Board Member Glyphic Biotechnologies2021 - 2024
Biotech Investor at OMX Ventures OMX Ventures2021 - 2024
Board Member Seeker Biologics2021 - 2023
Board Member Enara Bio2020 - 2021
Board Member Avilar Therapeutics2019 - 2021
Venture Investor RA Capital Management, LLC2019 - 2021
Co-Founder Hyku Biosciences2019 - 2021
Director Boehringer Ingelheim Venture Fund2019 - 2019
Board Of Directors Rewind Therapeutics2019 - 2019
Board Of Directors Tilos Therapeutics2018 - 2019
Senior Associate Director Boehringer Ingelheim Venture Fund2018 - 2019
Postdoctoral Research Fellow Pfizer2014 - 2018
Consultant Apple Tree Partners2017 - 2017
Technology Scouting Consultant BridgeBio2017 - 2017
Consultant SV Health Investors2017 - 2017
VentureLab Fellow Flagship Ventures2016 - 2016
Creator and Owner Detroit Ten Apparel2009 - 2014
Staff Researcher Salk Institute for Biological Studies2011 - 2013
Postdoctoral Researcher University of Notre Dame2011 - 2011
Biological Sciences PhD Student University of Notre Dame2006 - 2011